Titan Pharmaceuticals
TTNP
#10405
Rank
โ‚ฌ5.23 M
Marketcap
3,94ย โ‚ฌ
Share price
-3.76%
Change (1 day)
26.28%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -4,00ย โ‚ฌ

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,75ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -6,33ย โ‚ฌ an increase over its 2022 EPS that were of -12,97ย โ‚ฌ.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-4,00ย โ‚ฌ
2023-6,33ย โ‚ฌ-51.22%
2022-12,97ย โ‚ฌ-15.61%
2021-15,36ย โ‚ฌ-81.37%
2020-82,46ย โ‚ฌ-77.52%
2019-366,88ย โ‚ฌ-56.32%
2018-839,95ย โ‚ฌ-59.51%
2017-2.075ย โ‚ฌ-371.81%
2016763,28ย โ‚ฌ-144.35%
2015-1.721ย โ‚ฌ300%
2014-430,22ย โ‚ฌ-121.54%
20131.997ย โ‚ฌ-151.38%
2012-3.887ย โ‚ฌ-11.54%
2011-4.394ย โ‚ฌ188.89%
2010-1.521ย โ‚ฌ-10%
2009-1.690ย โ‚ฌ
2007-6.930ย โ‚ฌ-2.38%
2006-7.099ย โ‚ฌ-39.13%
2005-11.662ย โ‚ฌ-16.87%
2004-14.028ย โ‚ฌ-22.43%
2003-18.085ย โ‚ฌ4.9%
2002-17.239ย โ‚ฌ61.9%
2001-10.648ย โ‚ฌ-13.7%
2000-12.338ย โ‚ฌ67.14%
1999-7.382ย โ‚ฌ-35.87%
1998-11.511ย โ‚ฌ-1824.71%
1997667,42ย โ‚ฌ-102.4%
1996-27.865ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-1,21ย โ‚ฌ-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-0,21ย โ‚ฌ-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-2,89ย โ‚ฌ-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,91ย โ‚ฌ-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,28ย โ‚ฌ-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
0,02561ย โ‚ฌ-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA